Chemotherapy and Inpatient - Pharmacist Digest

Opinion: STAT+: One way to create resilient drug supply chains: incentivize predictive models

STAT

AUGUST 9, 2023

My first exposure to pharmaceutical shortages happened in 2017 as a new-to-practice nurse working on an inpatient oncology unit. Nearly 10 years ago, up to 83% of oncologists surveyed could not prescribe a preferred chemotherapy agent due to shortages. A hurricane in Puerto Rico had left the U.S. short of sodium chloride minibags.

Chemotherapy

Chemotherapy Inpatient

Assessing Prescriber Justification for Use of Outpatient Chemotherapy in the Acute Care Setting

Pharmacy Times

JUNE 17, 2025

This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.

Chemotherapy

Chemotherapy Inpatient

Back to Fundamental

RX Note

DECEMBER 16, 2023

Working As A Team Subconsciously, at work, hospital pharmacists have divided themselves to inpatient, outpatient, clinical, logistics, clinical pharmacokinetics, total parenteral nutrition and chemotherapy drug reconstitution services pharmacist. They can actively contribute their knowledge at other pharmacy departments.

Inpatient

Inpatient Chemotherapy Hospitals Labelling

Hospital Pharmacy FAQ

RX Note

AUGUST 4, 2023

You should be at least familiar with insulin and inhalers counselling before entering ward, inpatient or outpatient. You may also refresh knowledge of clinical pharmacokinetics , total parenteral nutrition or chemotherapy before entering the relevant rotations.

Hospitals

Hospitals Inpatient Community Pharmacies Dosage

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Pharmacy Times

JUNE 16, 2025

Transportation barriers, as a health-related social need, significantly impact FN rates in chemotherapy patients. Febrile neutropenia (FN) remains a serious and common complication of chemotherapy. A 67% FN rate difference between pegfilgrastim and filgrastim was observed in patients with transportation barriers.

Inpatient

Inpatient HIV Treatment and Prevention Agents Pharmacy Technician Chemotherapy

Episode 741: Is it safe to use early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia?

Pharmacy Joe

AUGUST 21, 2022

In this episode, I’ll discuss the safety of early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia. Episode 741: Is it safe to use early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia?

Chemotherapy

Chemotherapy Inpatient Labelling

Episode 741: Is it safe to use early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia?

Pharmacy Joe

AUGUST 21, 2022

In this episode, I’ll discuss the safety of early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia. Episode 741: Is it safe to use early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia?

Chemotherapy

Chemotherapy Inpatient Labelling

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Pharmacy Times

JUNE 17, 2025

Conclusions We demonstrated the feasibility of leveraging a complex EHR data source from an integrated health system to study the impact of dose modifications on clinical outcomes for self-administered chemotherapy. Nearly half of the patients with CML on imatinib experienced dosage modifications in this study.

Dosage

Dosage Pharmacy Technician Compounding Pharmacies Inpatient

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Pharmacy Times

JUNE 11, 2025

Approximately 40% to 80% of patients with cancer who are assigned female at birth face possible infertility as a result of their cancer treatments, such as chemotherapy, radiation, and surgery. An additional 15% to 30% of cancer survivors who are assigned male at birth also face infertility as a result of chemotherapy.

Pharmacy Technician

Pharmacy Technician Specialty Pharmacies Compounding Pharmacies Biosimilars

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Pharmacy Times

JUNE 17, 2025

Download Issue PDF Download RIS Articles in this issue The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD Assessing Prescriber Justification for Use of Outpatient (..)

Mail-Order Pharmacies

Mail-Order Pharmacies Pharmacy Technician Compounding Pharmacies Inpatient

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Pharmacy Times

JUNE 10, 2025

Related Videos Related Content Advertisement June 10th 2025 Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems Aislinn Antrim, Managing Editor June 3rd 2025 S2. December 21, 2004. Subscribe Now!

Pharmacy Technician

Pharmacy Technician HIV Treatment and Prevention Agents Compounding Pharmacies Biosimilars

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Pharmacy Times

JUNE 11, 2025

Additionally, patients may have received prior chemotherapy for advanced disease. Additionally, taletrectinib was granted priority review, breakthrough designation, and orphan drug designation for this indication. For both trials, the major efficacy outcomes were confirmed overall response rate (cORR) and duration of response (DOR).

Pharmacy Technician

Pharmacy Technician Biosimilars Compounding Pharmacies Pharmacy Management

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Pharmacy Times

JUNE 17, 2025

Martino, PharmD, BCOP, APh Kaitlyn Wells, PharmD Sam Martinez, PharmD, BCOP, BCPS Craig A. Stevens, PharmD, BCPS June 3rd 2025 S2. Martino, PharmD, BCOP, APh Kaitlyn Wells, PharmD Sam Martinez, PharmD, BCOP, BCPS Craig A. Stevens, PharmD, BCPS June 3rd 2025 S2.

Diabetes

Diabetes Pharmacy Technician Compounding Pharmacies Hospitals

Improving Quality of Life through Chronic Care Management

PharmD Live

MARCH 30, 2022

Ultimately, the person was diagnosed with digoxin toxicity due to renal complications of their newly diagnosed renal cancer and taking herbal preparation for cancer rather than chemotherapy. If the patient had a CCM service available, including pharmacists, I would not have cared for that patient in the ER that day.

Hospitals

Hospitals Inpatient Chemotherapy

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Pharmacy Times

JUNE 23, 2025

Download Issue PDF Download RIS Articles in this issue Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies Operationalizing Precision Oncology: The Expanding Role of the Clinical Precision Medicine (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Hospitals

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Pharmacy Times

JUNE 19, 2025

Trends Pharmacol Sci. 2024;45(5):406-418. doi:10.1016/j.tips.2024.03.004

Pharmacy Technician

Pharmacy Technician Diabetes Compounding Compounding Pharmacies

Learning Module

RX Note

JUNE 3, 2023

Inpatient Pharmacy Services Explain Floor stock, unit of dose and unit of use High alert medications Tall man lettering, sound-alike medication, look-alike medication Standard and end user item Floor stock list - How to decide min and max level List non-medical items that should be available in the emergency trolley.

Health and Personal Care Stores

Health and Personal Care Stores Chemotherapy Compounding Dosage

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Pharmacy Times

JUNE 20, 2025

Download Issue PDF Download RIS Articles in this issue Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies Operationalizing Precision Oncology: The Expanding Role of the Clinical Precision Medicine Oncology Pharmacist Sequencing of Liposomal Daunorubicin/Cytarabine (..)

Pharmacy Technician

Pharmacy Technician Compounding Compounding Pharmacies Biosimilars

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Pharmacy Times

JUNE 18, 2025

Download Issue PDF Download RIS Articles in this issue Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation The Value of a Medically (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Pharmacy Management

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Pharmacy Times

JUNE 18, 2025

Download Issue PDF Download RIS Articles in this issue Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation The Value of a Medically (..)

Pharmacy Technician

Pharmacy Technician Compounding Pharmacies Dosage Pharmacy Management

Pharmacist as Career - Pursuit if that is your passion Drug Information and Formulary Drug Information Services - The current roles Ministry of Health Medicines Formulary - Explaining MOHMF, Category of Prescribers, KPK application, Dossier Drug Formulary - Exploring the concept of drug formulary CME Presentation - Discussing expectations from audience (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Community Pharmacies Labelling Chemotherapy

Pharmacist Digest

Opinion: STAT+: One way to create resilient drug supply chains: incentivize predictive models

Assessing Prescriber Justification for Use of Outpatient Chemotherapy in the Acute Care Setting

Trending Sources

Back to Fundamental

Hospital Pharmacy FAQ

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

Episode 741: Is it safe to use early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia?

Episode 741: Is it safe to use early antibiotic discontinuation in hematology patients with fever of unknown origin during chemotherapy-induced neutropenia?

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Study: Prevalence and Clinical Implications of MASLD in Type 2 Diabetes

Improving Quality of Life through Chronic Care Management

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Learning Module

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

Contents

Stay Connected